{
  "report_rows": [
    {
      "kpi": "Organic Revenue Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~10.5-11% vs. cons 9.3%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS - Diluted Operating (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.57 vs. cons $3.47",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Mako Installations (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~105-115 units vs. cons 98 units",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Organic Growth (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~8-9.5% (maintain) vs. cons 8.81%",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Adj. EPS (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$14.90-$15.10 (maintain) vs. cons $14.98",
      "confidence": "HIGH"
    },
    {
      "kpi": "Gross/Op Margin Recovery Commentary (FY 2026)",
      "prediction": "BETTER",
      "answer": "Q2 gross margin recovery toward 65%+; 150bps+ op margin expansion on track",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE - maintained FY guide (not a raise) + elevated pre-print run limits follow-through; H2 recovery still a show-me story",
  "day5_confidence": "MEDIUM"
}